Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up()

BACKGROUND: Recently, attention has been focused on mesenchymal stem cells (MSC) because of their unique ability to suppress inflammation induced by cytokine storms caused by COVID-19. Several patients have been successfully treated in this manner. After one year of treatment with Wharton's jel...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Mahshid, Vaezi, Amir Abbas, Sohrabpour, Amir Ali, Barkhordar, Maryam, Aghaghazvini, Leila, Alijani, Neda, Verdi, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635897/
https://www.ncbi.nlm.nih.gov/pubmed/36373143
http://dx.doi.org/10.1016/j.genrep.2022.101691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635897/
https://www.ncbi.nlm.nih.gov/pubmed/36373143
http://dx.doi.org/10.1016/j.genrep.2022.101691

Ejemplares similares